Tiotropium: all 166 studies that test it
Page 2 of 2. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine ChallengeCompletedNCT02622243Phase 4
- 24hr Effects of Tiotropium Bromide in TetraplegiaCompletedNCT02586649Phase 2
- Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPDCompletedNCT02567214Phase 4
- Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMAStatus unknownNCT02546349Phase 4
- Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With BronchiectasisStatus unknownNCT02546297Phase 4
- Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPDCompletedNCT02541006Phase 4
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male SubjectsCompletedNCT02263976Phase 1
- Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male VolunteersCompletedNCT02259946Phase 1
- Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male VolunteersCompletedNCT02254174Phase 1
- Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02242253Phase 2
- Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male VolunteersCompletedNCT02177305Phase 1
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02175342Phase 2
- Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172794Phase 3
- Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female SubjectsCompletedNCT02172417Phase 1
- Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02172287Phase 3
- Evaluation of Long-Acting Muscarinic Antagonists in COPDCompletedNCT02039050Phase 4
- Ultra-long Acting Bronchodilator Therapy in AsthmaticsCompletedNCT02039011Phase 4
- Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPDCompletedNCT01693003Phase 4
- Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways FunctionStatus unknownNCT01466712Phase 4
- Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary DiseaseStatus unknownNCT01465906Phase 4
- Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in ChinaCompletedNCT01455129Phase 4
- Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCIStatus unknownNCT01355991Phase 1
- Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy VolunteersCompletedNCT01309139Phase 1
- Effects of Tiotropium on Walking Capacity in Patients With COPDCompletedNCT01307189Phase 4
- Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung CancerStatus unknownNCT01172925Phase 2
- Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00996697Phase 4
- Interaction in Chronic Obstructive Pulmonary Disease ExperimentCompletedNCT00981851Not applicable
- Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in KoreaCompletedNCT00864812Phase 4
- Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) PatientsTerminatedNCT00783250Phase 4
- Tiotropium and Salmeterol PK Study in COPD PatientsCompletedNCT00673478Phase 3
- Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT00568503Phase 1
- Effect of GSK1160724 In Healthy VolunteersCompletedNCT00555022Phase 1
- Tiotropium for Smoking Asthmatics StudyWithdrawnNCT00546234Phase 4
- Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00422604Phase 2
- Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During ExerciseCompletedNCT00412204Phase 4
- Effect of Tiotropium on Inflammation and Exacerbations in COPDCompletedNCT00405236Phase 4
- Tiotropium + Procaterol vs Tiotropium + Placebo in COPD PatientsTerminatedNCT00394485Phase 4
- Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.CompletedNCT00388882Phase 4
- An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent AsthmaCompletedNCT00365560Phase 2
- SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT00361959Phase 4
- Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00335621Phase 4
- A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPDCompletedNCT00308191Phase 3
- A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00292448Phase 2
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00281567Phase 3
- Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00279019Phase 1
- Spiriva® Assessment of FEV1 (SAFE)CompletedNCT00277264Phase 3
- Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
- A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedNCT00274560Phase 3
- Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274547Phase 3
- A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.CompletedNCT00274534Phase 3
- Tiotropium (Spiriva) Rehabilitation StudyCompletedNCT00274521Phase 3
- Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00274508Phase 3
- SPIRIVA in Ususal CareCompletedNCT00274079Phase 4
- Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of SpirivaCompletedNCT00274066Phase 3
- Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDCompletedNCT00274053Phase 3
- Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPDCompletedNCT00274040Phase 3
- Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)CompletedNCT00274027Phase 3
- Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory DisordersCompletedNCT00274014Phase 3
- Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
- Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDCompletedNCT00239460Phase 3
- Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPDCompletedNCT00239447Phase 3
- Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).CompletedNCT00239408Phase 4
- Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00157235Phase 3
- A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
- 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)CompletedNCT00144196Phase 4
- High Dose Trial in COPDCompletedNCT00128440Phase 2